Kent DM - Search Results

1

Risk prediction models for patients with chronic kidney disease: a systematic review.

Tangri N, Kitsios GD, Inker LA, Griffith J, Naimark DM, Walker S, Rigatto C, Uhlig K, Kent DM, Levey AS. Tangri N, et al. Among authors: kent dm. Ann Intern Med. 2013 Apr 16;158(8):596-603. doi: 10.7326/0003-4819-158-8-201304160-00004. Ann Intern Med. 2013. PMID: 23588748 Review.

2

The Framingham scores overestimated the risk for coronary heart disease in Japanese, Hispanic, and Native American cohorts.

Kent DM, Griffith J. Kent DM, et al. ACP J Club. 2002 Jan-Feb;136(1):36. ACP J Club. 2002. PMID: 11829577 No abstract available.

3

An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.

Kent DM, Hayward RA, Griffith JL, Vijan S, Beshansky JR, Califf RM, Selker HP. Kent DM, et al. Am J Med. 2002 Aug 1;113(2):104-11. doi: 10.1016/s0002-9343(02)01160-9. Am J Med. 2002. PMID: 12133748

4

Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.

Kent DM, Vijan S, Hayward RA, Griffith JL, Beshansky JR, Selker HP. Kent DM, et al. J Clin Epidemiol. 2004 Aug;57(8):843-52. doi: 10.1016/j.jclinepi.2004.01.008. J Clin Epidemiol. 2004. PMID: 15485737

5

Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.

Kent DM, Jafar TH, Hayward RA, Tighiouart H, Landa M, de Jong P, de Zeeuw D, Remuzzi G, Kamper AL, Levey AS. Kent DM, et al. J Am Soc Nephrol. 2007 Jun;18(6):1959-65. doi: 10.1681/ASN.2006101081. Epub 2007 May 2. J Am Soc Nephrol. 2007. PMID: 17475813

6

Against pragmatism: on efficacy, effectiveness and the real world.

Kent DM, Kitsios G. Kent DM, et al. Trials. 2009 Jul 6;10:48. doi: 10.1186/1745-6215-10-48. Trials. 2009. PMID: 19580642 Free PMC article.

7

Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay?

Concannon TW, Griffith JL, Kent DM, Normand SL, Newhouse JP, Atkins J, Beshansky JR, Selker HP. Concannon TW, et al. Among authors: kent dm. Circ Cardiovasc Qual Outcomes. 2009 Jan;2(1):9-15. doi: 10.1161/CIRCOUTCOMES.108.813741. Epub 2009 Jan 13. Circ Cardiovasc Qual Outcomes. 2009. PMID: 20031807 Free PMC article.

8

Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis.

Dahabreh IJ, Kitsios GD, Kent DM, Trikalinos TA. Dahabreh IJ, et al. Among authors: kent dm. Genet Med. 2010 Oct;12(10):606-15. doi: 10.1097/GIM.0b013e3181ee81c6. Genet Med. 2010. PMID: 20856122 Free PMC article. Review.

9

Accounting for center effects in multicenter trials.

Tangri N, Kitsios GD, Su SH, Kent DM. Tangri N, et al. Among authors: kent dm. Epidemiology. 2010 Nov;21(6):912-3. doi: 10.1097/EDE.0b013e3181f56fc0. Epidemiology. 2010. PMID: 20924234 No abstract available.

10

Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies.

Kitsios GD, Dahabreh IJ, Trikalinos TA, Schmid CH, Huggins GS, Kent DM. Kitsios GD, et al. Among authors: kent dm. Circ Cardiovasc Genet. 2011 Feb;4(1):58-67. doi: 10.1161/CIRCGENETICS.110.957738. Epub 2010 Dec 13. Circ Cardiovasc Genet. 2011. PMID: 21149552 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters